Mylan and federal investigators Thursday finalized a $465 million settlement of charges the drugmaker overcharged the government for the injection allergy medication EpiPen. Resolving an issue that ...
Despite reports of EpiPen shortages across the United States, one of the companies that manufactures the device said it is shipping the product -- "though supplies may vary from pharmacy to pharmacy." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results